Natraj Proteins Intrinsic Value
Natraj Proteins (NATRAJPR) median intrinsic value is ₹75.00 from 8 valuation models (range ₹19–₹95), vs current price ₹37.90 — +97.9% upside (Trading Below Calculated Value), margin of safety 49.5%. Browse NATRAJPR financial statements for revenue, profit, balance sheet and cash flow data.
NATRAJPR Valuation Methods Summary — DCF, Graham Number & P/E
Natraj Proteins intrinsic value across 8 models vs current price ₹37.90 — upside/downside and value range per method. For current market price and key ratios, visit NATRAJPR screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹36.36 | ₹29.09 - ₹43.63 | -4.1% | EPS: ₹3.03, Sector P/E: 12x |
| Book Value Method | asset | ₹82.50 | ₹74.25 - ₹90.75 | +117.7% | Book Value/Share: ₹82.50, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹75.80 | ₹68.22 - ₹83.38 | +100.0% | Revenue/Share: ₹252.50, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹60.00 | ₹54.00 - ₹66.00 | +58.3% | EBITDA: ₹4.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹94.75 | ₹75.80 - ₹113.70 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹19.39 | ₹17.45 - ₹21.33 | -48.8% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹24.24 | ₹21.82 - ₹26.66 | -36.0% | Revenue Growth: -8.6%, Adj P/E: 8.0x |
| Graham Defensive Method | conservative | ₹75.00 | ₹67.50 - ₹82.50 | +97.9% | EPS: ₹3.03, BVPS: ₹82.50 |
NATRAJPR Intrinsic Value vs Market Price — All Valuation Models
Natraj Proteins fair value range ₹19–₹95 vs current market price ₹37.90 across 8 valuation models. Also explore NATRAJPR stock price history to track price trends across different timeframes.
NATRAJPR Intrinsic Value Analysis — Undervalued or Overvalued?
Natraj Proteins median intrinsic value ₹75.00, current price ₹37.90 — Trading Below Calculated Value by 97.9%, margin of safety 49.5%.
What is the intrinsic value of NATRAJPR?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Natraj Proteins (NATRAJPR) is ₹75.00 (median value). With the current market price of ₹37.90, this represents a +97.9% variance from our estimated fair value.
The valuation range spans from ₹19.39 to ₹94.75, indicating ₹19.39 - ₹94.75.
Is NATRAJPR undervalued or overvalued?
Based on our multi-method analysis, Natraj Proteins (NATRAJPR) appears to be trading below calculated value by approximately 97.9%.
NATRAJPR Financial Health — Key Ratios vs Industry Benchmarks
Natraj Proteins financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 61.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 3.0% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 4.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.33x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
NATRAJPR Cash Flow Quality — Operating & Free Cash Flow
Natraj Proteins operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹22 Cr | ₹21 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹-6 Cr | ₹-6 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹3 Cr | ₹2 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹6 Cr | ₹5 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹9 Cr | ₹9 Cr | Positive Free Cash Flow | 8/10 |